rss
Gut 2004;53:1309-1313 doi:10.1136/gut.2003.031476
  • Inflammatory bowel disease

Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn’s disease patients: the Florence IBD study 1978–2001

  1. G Masala1,
  2. S Bagnoli2,
  3. M Ceroti1,
  4. C Saieva1,
  5. G Trallori2,
  6. I Zanna1,
  7. G d’Albasio3,
  8. D Palli1
  1. 1Molecular and Nutritional Epidemiology Unit, CSPO-Scientific Institute of Tuscany, Florence, Italy
  2. 2Department of Gastroenterology, AO Careggi, Florence, Italy
  3. 3Department of Gastroenterology, AO Careggi, Florence, Italy, and Regional IBD Referral Centre, Florence, Italy
  1. Correspondence to:
    Dr D Palli
    Molecular and Nutritional Epidemiology Unit, CSPO-Scientific Institute of Tuscany, Via di San Salvi 12, 50135 Florence, Italy; d.pallicspo.it
  • Accepted 20 January 2004

Abstract

Background and aims: Two divergent patterns of mortality for smoking related diseases in ulcerative colitis and Crohn’s disease patients were suggested in a previous population based study in Florence, Italy. Long term follow up (median 15 years) was completed to re-evaluate mortality in this Mediterranean cohort.

Patients and methods: Overall, 920 patients with inflammatory bowel disease were followed until December 2001 or death, with seven patients (0.8%) lost to follow up. A total of 14 040 person years were available for analysis; 118 deaths were observed (81/689 in ulcerative colitis and 37/231 in Crohn’s disease). Expected deaths were estimated using age, sex, and calendar specific national and local mortality rates; standardised mortality ratios (SMR) and 95% confidence interval (CI) were calculated.

Results: Among Crohn’s disease patients, mortality was strongly increased for gastrointestinal diseases (SMR 4.49 (95% CI 1.80–9.25)), all cancers (SMR 2.10 (95% CI 1.22–3.36)), and lung cancer (SMR 4.00 (95% CI 1.60–8.24)), leading to a significant 50% excess total mortality. Ulcerative colitis patients showed a significantly reduced total mortality because of lower cardiovascular (SMR 0.67 (95% CI 0.45–0.95)) and lung cancer (SMR 0.32 (95% CI 0.07–0.95)) mortality. No significant excess for colorectal cancer mortality was evident in this extended follow up.

Conclusions: These clearly divergent patterns of mortality correlate with documented differences in smoking habits between Crohn’s disease and ulcerative colitis patients. Family doctors and gastroenterologists should consider stopping cigarette smoking a specific priority for Crohn’s disease patients; the latter should be offered free participation in structured programmes for smoking cessation, with the aim of reducing smoking related excess mortality. Overall, no evidence of an increased mortality for large bowel cancer emerged in this series.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Services

    1. Email this link to a friend
    2. Alert me when this article is cited
    3. Alert me if a correction is posted
    4. Article Usage Statistics
    5. Similar articles in this journal
    6. Similar articles in Web of Science
    7. Similar articles in PubMed
    8. Add article to my folders
    9. Download to citation manager
    10. Request permissions

    Social bookmarking

    Latest from Gut Education

    Latest from Gut Education

    Register for free content


    Free sample
     This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Gut.
    View free sample issue >>

    Free archive
    The full back archive is now available for Gut. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.